MXL Insider Plans to Sell 102,157 Shares via Morgan Stanley ($1.77M)
Rhea-AI Filing Summary
MaxLinear, Inc. (MXL) filed a Form 144 notifying a proposed sale of 102,157 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $1,765,108.49. The filing lists approximately 87,080,498 shares outstanding and an approximate sale date of 08/26/2025. The securities to be sold were acquired in three grants: 1,277 shares via an Employee Stock Purchase Plan on 05/17/2021, 47,725 restricted shares on 02/22/2019, and 53,155 performance shares on 02/17/2021. No sales by the seller were reported in the past three months. The signer certifies they have no undisclosed material adverse information about the issuer.
Positive
- Transparent disclosure of the number of shares and acquisition types (ESPP, restricted, performance) supporting compliance
- Brokered sale through Morgan Stanley Smith Barney suggests an orderly transaction rather than distressed selling
- No sales in past three months indicates the filer has not been actively disposing of large holdings recently
Negative
- None.
Insights
TL;DR: Routine insider sale notice for 102,157 shares valued at $1.77M; appears procedural, not an earnings or operational signal.
This Form 144 reports a proposed sale by a person holding shares acquired from an ESPP, restricted stock, and performance shares. The sale size represents about 0.12% of the reported outstanding shares (102,157 of 87,080,498). The use of a major brokerage and the absence of recent sales suggest a planned, orderly disposition rather than urgent liquidation. There is no disclosure of material nonpublic information; the filer makes the standard certification.
TL;DR: Governance process followed: required disclosure filed and seller attests to no undisclosed material information.
The Form 144 provides the required regulatory notice for selling restricted and performance-based equity. Acquisition dates and grant types are disclosed, which supports transparency around insider liquidity. The filing notes no sales in the prior three months, aligning with controlled selling practices. This is a routine compliance filing rather than a governance red flag.